Every financial results announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Workmates Core2Cloud approved FY26 financial results and a ₹2.58 Crore interim dividend. The company reported standalone annual profit of ₹16.38 Crore on strong revenue growth.
Fujiyama Power Systems approved financial results and a ₹35.00 Crore expansion for a solar cell facility. A fire incident at Bawal caused ₹157.63 Crore damage.
Diensten Tech Limited reported its audited consolidated and standalone financial results for FY2026. The board approved the performance figures during their May 14 meeting.
Pearl Global Industries approved FY26 financial results and a second interim dividend of ₹8.50 per share. It also acquired a 9.99% stake in PT Pinnacle Apparels.
Forbes & Company Limited reported its audited financial results for the year ended March 31, 2026. The company also announced the appointment of a new Company Secretary.
Eleganz Interiors Limited reported audited consolidated net profit of ₹22.11 Crore for FY2026. The Board also appointed M/s KDA & Associates as Secretarial Auditors for FY2026-27.
Suntech Infra Solutions reported a total income of ₹179.16 Crore for FY2026. The board also approved the appointment of new statutory auditors following GSRA's resignation.
Pro Fin Capital Services reported unaudited financial results for the December 2025 quarter. The board approved the results, which show standalone performance for the period.
Endurance Technologies reported audited financial results for the year ended March 2026 and recommended a ₹11.50 per share dividend. Key board leadership changes were also announced.
Comfort Intech approved audited standalone and consolidated FY2026 results and recommended a 5% dividend. The Board also noted the resignation of its Company Secretary.
J.G. Chemicals Limited reported audited financial results for the year ended March 2026 and recommended a 11% dividend. The board also re-appointed key auditors.
Alivus Life Sciences approved FY2025-26 audited results and recommended a ₹5 per share final dividend. The company reported annual revenue from operations of ₹2,551.83 Crore.